Understanding how DNA sequences affect immune cell development
DNA sequence selectivity in conventional and aberrant V(D)J recombination
This study looks at how certain DNA sequences help immune cells, like B and T cells, create a variety of receptors to fight off infections, while also trying to understand how this process can sometimes go wrong and cause problems, which could help us learn more about the immune system and related diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma Hlth Sciences Ctr NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project ID | NIH-10900637 on NIH RePORTER |
What this research studies
This research investigates the process of V(D)J recombination, which is crucial for generating diverse antigen receptors in immune cells. It focuses on how specific DNA sequences influence the efficiency and accuracy of this recombination process, which occurs during the development of B and T cells. By utilizing a high-throughput method to analyze various recombination signal sequences, the study aims to uncover the balance between successful immune receptor formation and the risk of harmful chromosomal rearrangements. This could lead to a better understanding of immune system function and its implications for diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with immune system disorders or those interested in the genetic basis of immune responses.
Not a fit: Patients with non-immune related conditions or those not affected by immune system disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of immune system disorders and lead to improved therapies for related diseases.
How similar studies have performed: Previous research has shown promising results in understanding V(D)J recombination, but this specific approach to analyzing DNA sequence selectivity is relatively novel.
Where this research is happening
Oklahoma City, United States
- University of Oklahoma Hlth Sciences Ctr — Oklahoma City, United States (Active)
Researchers
- Principal investigator: Rodgers, Karla K — University of Oklahoma Hlth Sciences Ctr
- Study coordinator: Rodgers, Karla K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.